HomeCompareHYMTF vs PFE

HYMTF vs PFE: Dividend Comparison 2026

HYMTF yields 1.40% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HYMTF wins by $14.95M in total portfolio value
10 years
HYMTF
HYMTF
● Live price
1.40%
Share price
$51.00
Annual div
$0.71
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$14.99M
Annual income
$13,182,202.15
Full HYMTF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — HYMTF vs PFE

📍 HYMTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHYMTFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HYMTF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HYMTF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HYMTF
Annual income on $10K today (after 15% tax)
$118.75/yr
After 10yr DRIP, annual income (after tax)
$11,204,871.83/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, HYMTF beats the other by $11,182,551.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HYMTF + PFE for your $10,000?

HYMTF: 50%PFE: 50%
100% PFE50/50100% HYMTF
Portfolio after 10yr
$7.52M
Annual income
$6,604,230.43/yr
Blended yield
87.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

HYMTF
No analyst data
Altman Z
1.3
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HYMTF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHYMTFPFE
Forward yield1.40%6.13%
Annual dividend / share$0.71$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$14.99M$49.6K
Annual income after 10y$13,182,202.15$26,258.71
Total dividends collected$14.83M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HYMTF vs PFE ($10,000, DRIP)

YearHYMTF PortfolioHYMTF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$10,979$279.41$9,153$693.39+$1.8KHYMTF
2$12,321$573.41$8,593$849.25+$3.7KHYMTF
3$14,387$1,202.79$8,336$1,066.78+$6.1KHYMTF
4$18,019$2,625.05$8,437$1,384.80+$9.6KHYMTF
5$25,425$6,145.38$9,013$1,875.40+$16.4KHYMTF
6$43,414$16,208.35$10,306$2,680.72+$33.1KHYMTF
7$98,182$51,729.91$12,820$4,101.38+$85.4KHYMTF
8$323,729$218,673.43$17,673$6,826.70+$306.1KHYMTF
9$1,694,078$1,347,688.38$27,543$12,591.86+$1.67MHYMTF
10$14,994,866$13,182,202.15$49,560$26,258.71+$14.95MHYMTF

HYMTF vs PFE: Complete Analysis 2026

HYMTFStock

Hyundai Motor Company, together with its subsidiaries, manufactures and distributes motor vehicles and parts worldwide. It operates through Vehicle, Finance, and Others segments. The company offers cars under the Azera, Sonata, Veloster, Veloster N, i30 Fastback N, The new i30, i30 N, The all-new Elantra, Accent, i20 N, i20, The all-new Elantra N, and i10 names; and SUVs under the Palisade, Santa Fe, The all-new Tucson, Creta, The new Kona, KONA N, and Venue names. It also provides commercial vehicles under the STARIA, H-1, and H-100 names; and eco vehicles under the IONIQ 5, NEXO, Santa Fe Hybrid/Plug-in Hybrid, The all-new Tucson Hybrid, The all-new Tucson Plug-in Hybrid, KONA Electric, The all-new Elantra Hybrid, IONIQ Plug-in Hybrid, IONIQ Electric, IONIQ Hybrid, and The new i30 Hybrid names. In addition, the company offers trucks, buses, vans, engines; vehicle financing, credit card processing, and other financing activities; train manufacturing services and other activities; and marketing, engineering, mobility, and insurance services, as well as operates a football club. Further, it is involved in real estate development; research and development; and investment activities. Hyundai Motor Company was incorporated in 1967 and is headquartered in Seoul, South Korea.

Full HYMTF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this HYMTF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HYMTF vs SCHDHYMTF vs JEPIHYMTF vs OHYMTF vs KOHYMTF vs MAINHYMTF vs JNJHYMTF vs MRKHYMTF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.